Bethesda, MD, United States of America

Carlos A Velikovsky

This inventor holds 1 USPTO granted patent. Top assignee: University System of Maryland. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carlos A Velikovsky. Retrieved from https://idiyas.com/inventor/carlos-a-velikovsky

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Carlos A. Velikovsky: Innovator in Antibody Technology

Introduction

Carlos A. Velikovsky is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of innovative antibody technologies. His work has implications for various diagnostic applications and protein engineering.

Latest Patents

Carlos A. Velikovsky holds a patent for "High affinity recombinant sea lamprey antibodies selected by a Yeast Surface Display platform." This invention relates to a Yeast Surface Display (YSD) vector designed for the expression of VLR proteins by yeast. The vector includes nucleotide sequences encoding segments of yeast flocculation proteins Flo1p, such as the leader and C-terminal segments, a homologous recombinant cassette, and a geneticin/kanamycin resistance gene. This vector can be utilized for the expression of VLR that may be effective in diagnostic applications, immunoaffinity purification, and for engineering novel fusion proteins. He has 1 patent to his name.

Career Highlights

Carlos A. Velikovsky is affiliated with the University System of Maryland, where he continues to advance research in antibody technology. His work is characterized by a commitment to innovation and practical applications in the field of biotechnology.

Collaborations

He has collaborated with notable colleagues such as Satoshi Tasumi and Zeev Pancer, contributing to a dynamic research environment that fosters innovation.

Conclusion

Carlos A. Velikovsky's contributions to antibody technology exemplify the intersection of research and practical application in biotechnology. His innovative work continues to influence the field and pave the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…